D-2-HG accumulates in isocitrate dehydrogenase (IDH)-mutant acute myeloid leukemia (AML) and impairs dendritic cells (DC) differentiation, leading to a tolerogenic phenotype with reduced major histocompatibility complex class II (MHC class II) expression. The gene discussed is IDH3A; the disease is acute myeloid leukemia.